{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T04:58:21Z","timestamp":1781326701318,"version":"3.54.1"},"reference-count":34,"publisher":"BMJ","issue":"7","license":[{"start":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T00:00:00Z","timestamp":1722297600000},"content-version":"unspecified","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012618","name":"National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology","doi-asserted-by":"publisher","award":["no award number"],"award-info":[{"award-number":["no award number"]}],"id":[{"id":"10.13039\/501100012618","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000317","name":"Action Medical Research","doi-asserted-by":"publisher","award":["GN2617"],"award-info":[{"award-number":["GN2617"]}],"id":[{"id":"10.13039\/501100000317","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2024,7,8]]},"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>This study aimed to evaluate the safety of dichoptic balanced binocular viewing (BBV) for amblyopia in children, plus feasibility, adherence, acceptability, trial methodology and clinical measures of visual function.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>We carried out an observer-masked parallel-group phase 2a feasibility randomised controlled trial.<\/jats:p><\/jats:sec><jats:sec><jats:title>Setting<\/jats:title><jats:p>Two study sites, a secondary\/tertiary and a community site.<\/jats:p><\/jats:sec><jats:sec><jats:title>Participants<\/jats:title><jats:p>We enrolled 32 children aged 3\u20138 years with unilateral amblyopia who had completed optical adaptation where indicated. 20 children attended the 16-week exit visit (retention 63%).<\/jats:p><\/jats:sec><jats:sec><jats:title>Interventions<\/jats:title><jats:p>Children were randomised to BBV (movies customised to interocular acuity difference at baseline) for 1\u2009hour a day (active intervention) or standard management as per parental choice (part-time occlusion or atropine blurring, control). All interventions were used at home, daily for 16 weeks.<\/jats:p><\/jats:sec><jats:sec><jats:title>Primary outcome measure<\/jats:title><jats:p>\u2018VacMan suppression test\u2019 of interocular balance at 16 weeks from randomisation. Secondary outcome measures: feasibility outcomes (recruitment and retention ratios, adherence with the allocated intervention); safety outcomes at other time points (changes in prevalence of diplopia, manifest strabismus, suppression\/interocular balance on a range of tests); efficacy outcomes (clinical measures of visual function, such as best-corrected visual acuity, BCVA). Outcome measures were identical to those planned in the protocol.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Primary outcome: At baseline, values for the interocular balance point were higher (indicating greater suppression of the amblyopic eye) in the occlusion group than in the BBV group. These values shifted downwards on average for the occlusion group, significantly decreasing from baseline to week 16 (t<jats:sub>8<\/jats:sub>=4.49, p=0.002). Balance values did not change between baseline and week 16 for the BBV group (t<jats:sub>9<\/jats:sub>=\u22120.82, p=0.435). At 16 weeks, there was no statistical difference in interocular balance\/suppression change over time between the two arms. The difference at follow-up between the arms, adjusted for baseline, was \u22120.02 (95% CI \u22120.28 to 0.23, p=0.87). Feasibility: We prescreened 144 records of potentially eligible children. Between 28 October 2019 and 31 July 2021, including an interruption due to the COVID-19 pandemic, 32 children were screened and randomised (recruitment rate 22%), 16 to BBV and 16 to standard treatment. 20 children attended the 16-week exit visit (retention 63%). Mean adherence with BBV as proportion of viewing time prescribed was 56.1% (SD36) at 8 and 57.9% (SD 30.2) at 16 weeks. Mean adherence with prescribed occlusion time was 90.1% (SD 19.7) at 8 and 59.2% (SD 24.8) at 16 weeks.<\/jats:p><\/jats:sec><jats:sec><jats:title>Secondary safety\/efficacy outcomes<\/jats:title><jats:p>One child in the BBV arm reported transient double vision, which resolved; two reported headaches, which led to withdrawal. BCVA improved from mean 0.47 (SD0.18) logMAR at randomisation to 0.26 (0.14) with standard treatment, and from 0.55 (0.28) to 0.32 (0.26) with BBV. Outcomes at 16 weeks did not differ between treatments.<\/jats:p><\/jats:sec><jats:sec><jats:title>Participant experience<\/jats:title><jats:p>Families were generally positive about BBV, but families found both patching and BBV difficult to integrate into family routines.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Recruitment rates indicate that a future phase 3 trial will require multiple sites or a longer enrolment period. Retention and adherence rates were lower than anticipated, which will influence future study designs. Dichoptic treatment may be equal to occlusion treatment in safety and efficacy; headaches may lead to discontinuation. Integration into family routines may constitute a barrier to implementation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration number<\/jats:title><jats:p><jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT03754153\">NCT03754153<\/jats:ext-link>.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bmjopen-2023-082472","type":"journal-article","created":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T02:58:39Z","timestamp":1722394719000},"page":"e082472","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":7,"title":["Feasibility of a new \u2018balanced binocular viewing\u2019 treatment for unilateral amblyopia in children aged 3\u20138 years (BALANCE): results of a phase 2a randomised controlled feasibility trial"],"prefix":"10.1136","volume":"14","clinical-trial-number":[{"clinical-trial-number":"nct03754153","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7402-4350","authenticated-orcid":false,"given":"Annegret Hella","family":"Dahlmann-Noor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6184-0818","authenticated-orcid":false,"given":"John A","family":"Greenwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9573-372X","authenticated-orcid":false,"given":"Andrew","family":"Skilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0161-443X","authenticated-orcid":false,"given":"Daniel","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Clay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payal","family":"Khandelwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Dunham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siobhan","family":"Ludden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakim-Moulay","family":"Dehbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven C","family":"Dakin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,7,30]]},"reference":[{"key":"2024073019551239000_14.7.e082472.1","doi-asserted-by":"publisher","DOI":"10.1093\/bmb\/ldw030"},{"key":"2024073019551239000_14.7.e082472.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(98)91862-0"},{"key":"2024073019551239000_14.7.e082472.3","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.13-11861"},{"key":"2024073019551239000_14.7.e082472.4","article-title":"Binocular versus standard occlusion or blurring treatment for unilateral amblyopia in children aged three to eight years","volume":"2015","author":"Tailor","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"2024073019551239000_14.7.e082472.5","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1001\/jamaophthalmol.2016.4262","article-title":"Effect of a binocular ipad game vs part-time patching in children aged 5 to 12 years with amblyopia: a randomized clinical trial","volume":"134","author":"Holmes","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"2024073019551239000_14.7.e082472.6","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1001\/jamaophthalmol.2017.6090","article-title":"Effectiveness of A binocular video game vs placebo video game for improving visual functions in older children, teenagers, and adults with amblyopia: A randomized clinical trial","volume":"136","author":"Gao","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"2024073019551239000_14.7.e082472.7","doi-asserted-by":"crossref","first-page":"e423","DOI":"10.1111\/aos.14595","article-title":"Effect of dichoptic video game treatment on mild amblyopia - a pilot study","volume":"99","author":"Pang","year":"2021","journal-title":"Acta Ophthalmol"},{"key":"2024073019551239000_14.7.e082472.8","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1001\/jamaophthalmol.2016.4224","article-title":"Binocular ipad game vs patching for treatment of amblyopia in children: a randomized clinical trial","volume":"134","author":"Kelly","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"2024073019551239000_14.7.e082472.9","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ophtha.2018.10.032","article-title":"A randomized trial of binocular dig rush game treatment for amblyopia in children aged 7 to 12 years","volume":"126","author":"Holmes","year":"2019","journal-title":"Ophthalmology"},{"key":"2024073019551239000_14.7.e082472.10","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/OPX.0000000000001867","article-title":"A randomized trial of binocular dig rush game treatment for amblyopia in children aged 4 to 6 years","volume":"99","author":"Manny","year":"2022","journal-title":"Optom Vis Sci"},{"key":"2024073019551239000_14.7.e082472.11","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1167\/iovs.16-20913","article-title":"Binocular therapy for childhood amblyopia improves vision without breaking interocular suppression","volume":"58","author":"Bossi","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2024073019551239000_14.7.e082472.12","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-08010-9","article-title":"Randomized clinical trial of streaming dichoptic movies versus patching for treatment of amblyopia in children aged 3 to 7years","volume":"12","author":"Jost","year":"2022","journal-title":"Sci Rep"},{"key":"2024073019551239000_14.7.e082472.13","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ophtha.2021.09.001","article-title":"Randomized controlled trial of a dichoptic digital therapeutic for amblyopia","volume":"129","author":"Xiao","year":"2022","journal-title":"Ophthalmology"},{"key":"2024073019551239000_14.7.e082472.14","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3109\/09273972.2016.1170048","article-title":"Assessment of the density of suppression to identify risk of intractable diplopia in the United Kingdom","volume":"24","author":"Newsham","year":"2016","journal-title":"Strabismus"},{"key":"2024073019551239000_14.7.e082472.15","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2017-310454"},{"key":"2024073019551239000_14.7.e082472.16","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/opo.12108","article-title":"Binocular fusion, suppression and diplopia for blurred edges","volume":"34","author":"Georgeson","year":"2014","journal-title":"Ophthalmic Physiologic Optic"},{"key":"2024073019551239000_14.7.e082472.17","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.16-20438"},{"key":"2024073019551239000_14.7.e082472.18","doi-asserted-by":"crossref","DOI":"10.1136\/bmjophth-2021-000914","article-title":"Reasons why we might want to question the use of patching to treat amblyopia as well as the reliance on visual acuity as the primary outcome measure","volume":"7","author":"Hess","year":"2022","journal-title":"BMJ Open Ophthalmol"},{"key":"2024073019551239000_14.7.e082472.19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0100156","article-title":"Assessing binocular interaction in amblyopia and its clinical feasibility","volume":"9","author":"Kwon","year":"2014","journal-title":"PLoS ONE"},{"key":"2024073019551239000_14.7.e082472.20","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.visres.2018.09.006","article-title":"A comparison of tests for quantifying sensory eye dominance","volume":"153","author":"Bossi","year":"2018","journal-title":"Vis Res"},{"key":"2024073019551239000_14.7.e082472.21","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-051423","article-title":"Phase 2a randomised controlled feasibility trial of a new \u201cbalanced binocular viewing\u201d treatment for unilateral amblyopia in children age 3-8 years: trial protocol","volume":"12","author":"Dahlmann-Noor","year":"2022","journal-title":"BMJ Open"},{"key":"2024073019551239000_14.7.e082472.22","doi-asserted-by":"crossref","unstructured":"Martin-Kerry J , Bower P , Young B , et al . n.d. Developing and evaluating multimedia information resources to improve engagement of children, adolescents, and their parents with trials (TRECA study): study protocol for a series of linked randomised controlled trials. doi:10.1186\/ISRCTN73136092","DOI":"10.1186\/ISRCTN73136092"},{"key":"2024073019551239000_14.7.e082472.23","doi-asserted-by":"crossref","unstructured":"Martin-Kerry J , Parker A , Bower P , et al . SWATted away: the challenging experience of setting up a programme of swats in paediatric trials. Trials 2019;20. doi:10.1186\/s13063-019-3236-4","DOI":"10.1186\/s13063-019-3236-4"},{"key":"2024073019551239000_14.7.e082472.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2004.04.032"},{"key":"2024073019551239000_14.7.e082472.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaapos.2009.08.009"},{"key":"2024073019551239000_14.7.e082472.26","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.121.5.603"},{"key":"2024073019551239000_14.7.e082472.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2003.08.001"},{"key":"2024073019551239000_14.7.e082472.28","doi-asserted-by":"publisher","DOI":"10.1191\/1478088706qp063oa"},{"key":"2024073019551239000_14.7.e082472.29","doi-asserted-by":"publisher","DOI":"10.3758\/BF03202828"},{"key":"2024073019551239000_14.7.e082472.30","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3109\/09273972.2016.1170047","article-title":"Dynamics of interocular suppression in amblyopic children during electronically monitored occlusion therapy: first insight","volume":"24","author":"Kehrein","year":"2016","journal-title":"Strabismus"},{"key":"2024073019551239000_14.7.e082472.31","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.12-10313"},{"key":"2024073019551239000_14.7.e082472.32","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1007\/s00417-021-05193-1","article-title":"Barriers to successful dichoptic treatment for amblyopia in young children","volume":"259","author":"Kadhum","year":"2021","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2024073019551239000_14.7.e082472.33","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1748-5908-6-42","article-title":"The behaviour change wheel: A new method for characterising and designing behaviour change interventions","volume":"6","author":"Michie","year":"2011","journal-title":"Implementation Sci"},{"key":"2024073019551239000_14.7.e082472.34","doi-asserted-by":"publisher","DOI":"10.2165\/11599120-000000000-00000"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2023-082472","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T02:58:59Z","timestamp":1722394739000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2023-082472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":34,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,7,30]]},"published-print":{"date-parts":[[2024,7]]}},"alternative-id":["10.1136\/bmjopen-2023-082472"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2023-082472","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7]]}}}